Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 109-115
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
Raffaele Izzo, Valentina Trimarco, Pasquale Mone, et al.
Pharmacological Research (2022) Vol. 183, pp. 106360-106360
Open Access | Times Cited: 73
COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 48
Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
Pasquale Mone, Angela Lombardi, Urna Kansakar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 116-122
Open Access | Times Cited: 66
Intestinal barrier dysfunction as a key driver of severe COVID-19
Efthymios P. Tsounis, Christos Triantos, Christos Konstantakis, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 68-90
Open Access | Times Cited: 24
Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial
Valentina Trimarco, Raffaele Izzo, Angela Lombardi, et al.
Pharmacological Research (2023) Vol. 191, pp. 106702-106702
Open Access | Times Cited: 20
Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 1, pp. 34-39
Open Access | Times Cited: 8
Intrinsic factors behind long‐COVID: I. Prevalence of the extracellular vesicles
Yousra A. El‐Maradny, Alberto Rubio‐Casillas, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 5, pp. 656-673
Closed Access | Times Cited: 11
COVID-19 patient serum-derived extracellular vesicles deliver miR-20b-5p induces neutrophil extracellular traps
Yao Liao, Yuheng Liu, Dinghao Li, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Emerging functions and clinical applications of exosomal microRNAs in diseases
Soudeh Ghafouri‐Fard, Hamed Shoorei, Peixin Dong, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 3, pp. 350-362
Open Access | Times Cited: 10
Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From Mycoplasma-Induced Respiratory Disease to COVID-19 and Beyond
Yingjie Wang, Mengyun Zou, Yabo Zhao, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2421-2421
Open Access | Times Cited: 10
Differentially‐regulated miRNAs in COVID‐19: A systematic review
Waqar Ahmad, Bushra Gull, Jasmin Baby, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Open Access | Times Cited: 9
Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study
Pouria Azami, Reza Golchin Vafa, Reza Heydarzadeh, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases
Owais Mohmad Bhat, Rakeeb Ahmad Mir, Iqra Bashir Nehvi, et al.
IJC Heart & Vasculature (2024) Vol. 53, pp. 101469-101469
Open Access | Times Cited: 3
Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis
María Cristina Negrete-García, Javier de Jesús Ramos-Abundis, Noé Alvarado‐Vásquez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11047-11047
Open Access | Times Cited: 14
Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
Martina Schiavello, Barbara Vizio, Ornella Bosco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1920-1920
Open Access | Times Cited: 7
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles
Valentina Di Salvatore, Elena Crispino, Avisa Maleki, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3339-3354
Open Access | Times Cited: 7
The relationship between microRNAs and COVID-19 complications
Abdollah Kebriaei, Reza Besharati, Hasan Namdar Ahmad Abad, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 16-24
Open Access | Times Cited: 2
In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19
Angela Lombardi, Shivani Agarwal, Clyde B. Schechter, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2683-2688
Open Access | Times Cited: 11
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
Silvia Martínez-Diz, Carmen María Morales-Álvarez, Yarmila Garcia-Iglesias, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
MiRNAs and Their Role in Venous Thromboembolic Complications
Ilgiz Gareev, В. Н. Павлов, Weijie Du, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 5
Extracellular Vesicles and Their Role in Lung Infections
Shadi Hambo, Hani Harb
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16139-16139
Open Access | Times Cited: 5
Controlling viral inflammatory lesions by rebalancing immune response patterns
Sachin Mulik, Engin Berber, Sharvan Sehrawat, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Differences in leucocytes and inflammation-based indices among critically ill patients owing to SARS-CoV-2 variants during several successive waves of COVID-19 pandemic
Awatef Ben Jemaa, Ridha Oueslati, Jihene Guissouma, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110836-110836
Closed Access | Times Cited: 4
Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial
Beverley Greenwood-Van Meerveld, Roberto Levi, Eric R. Gross, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 1, pp. 1-5
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top